Sign the Epilepsy Research and Medical Marijuana Petition!
The Epilepsy Foundation of America has started a petition on the White House website. We need your help! We are calling on the President and the Drug Enforcement Administration to reschedule marijuana to a lower level under the controlled substances act. The Foundation supports this change to benefit greater access to marijuana and its [...]Learn more
ONFI (clobazam) Tablets now Available in the U.S. at Pharmacies
DEERFIELD, Ill.–(BUSINESS WIRE)–Lundbeck announced today that ONFI Tablets are now available for prescribing in the United States. The FDA recently approved ONFI for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years and older.1 ONFI is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine.1 ONFI [...]Learn more
Drug Shortage Alert
Drug Shortage Alert: Pfizer Announces DILANTIN® 30 mg (Extended Phenytoin Sodium Capsules, USP) Shortage The Epilepsy Foundation has learned that Pfizer is contacting health care professionals, including pharmacists, about a shortage of DILANTIN 30 mg. According to Pfizer, this product shortage is due to a manufacturing issue and not the result of any performance or [...]Learn more